Drugs that contain Metformin Hydrochloride; Pioglitazone Hydrochloride
1. List of Actoplus Met drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9101660 | TAKEDA PHARMS USA | Solid preparation |
Jan, 2027
(3 years from now) | |
| US9320714 | TAKEDA PHARMS USA | Tablet |
Feb, 2029
(5 years from now) | |
Market Authorisation Date: 29 August, 2005
Treatment: NA
Dosage: TABLET;ORAL
ACTOPLUS MET family patents
7
Japan
4
United States
2
Canada
2
Korea, Republic of
2
Spain
2
New Zealand
2
Portugal
2
European Union
1
Poland
1
Slovenia
1
Ukraine
1
Brazil
1
Hong Kong
1
Costa Rica
1
China
1
Morocco
1
Denmark
1
Mexico
1
Colombia
1
Australia
1
Norway
1
South Africa
1
Russia
1
Israel
1
Cyprus
2. List of Actoplus Met Xr drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8470368 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep, 2023
(3 months from now) | |
| US8668931 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep, 2023
(3 months from now) | |
| US9060941 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep, 2023
(3 months from now) | |
| US7785627 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Jul, 2026
(3 years from now) | |
| US7959946 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Jul, 2026
(3 years from now) | |
Market Authorisation Date: 12 May, 2009
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
ACTOPLUS MET XR family patents
17
United States
7
Korea, Republic of
6
Japan
5
China
4
Australia
4
European Union
3
Canada
3
Hong Kong
3
Spain
3
New Zealand
2
Brazil
2
Taiwan
1
Peru
1
Georgia
1
Ukraine
1
Costa Rica
1
Morocco
1
Argentina
1
Mexico
1
EA
1
Norway
1
South Africa
1
Singapore
1
Israel
1
Malaysia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic